← Back to Clinical Trials
Recruiting NCT06991192

NCT06991192 ACL Reconstruction Rehabilitation With Exercise and Psychological Support

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06991192
Status Recruiting
Phase
Sponsor HealthPartners Institute
Condition Anterior Cruciate Ligament Reconstruction Rehabilitation
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-05-01
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 21 Years
Study Type INTERVENTIONAL
Interventions
Rehabilitation with Exercise and Psychological Support (REPS)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-05-01 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to examine ACLR Rehabilitation with Exercise and Psychological Support (REPS), comparing two approaches for providing psychological support along with exercise during ACL reconstruction rehabilitation. In one group, physical therapists have received training that may boost emotional support during rehabilitation. In the other group, physical therapists will not have the training. Both groups will get similar exercises and participate in the same testing. Both groups will also watch short videos during rehabilitation that are specific to their group. Participants will not know to which group they are assigned until the end of the study. Participation will attend a total of four study visits over the course of 6 months, including 1 visit before the surgery and 3 visits during follow-up.

Eligibility Criteria

Inclusion Criteria: * Age 15 to 21 years at the time of surgery; * Pre-injury Tegner Activity Rating60 ≥ 5 (5=recreational sports, 10=elite sports); * Sports participation at least 100 hours/year prior to injury; * Intent to resume a pre-injury sport that requires cutting, jumping, or pivoting; * ACL reconstruction performed ≤ 6 months from injury; * ACL reconstruction performed with bone-patellar tendon-bone autograft or quadriceps tendon autograft; and * Able to complete rehabilitation at one of the 4 participating TRIA locations. Exclusion Criteria: * Previous ACL injury or surgery to either limb; * Concomitant ligamentous injury \> Grade II or requiring surgery; and * Surgical procedure to articular cartilage requiring non-weight-bearing after surgery.

Contact & Investigator

Central Contact

TRIA Research

✉ TRIAResearch@tria.com

📞 952-806-5603

Frequently Asked Questions

Who can join the NCT06991192 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 21 Years, studying Anterior Cruciate Ligament Reconstruction Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06991192 currently recruiting?

Yes, NCT06991192 is actively recruiting participants. Contact the research team at TRIAResearch@tria.com for enrollment information.

Where is the NCT06991192 trial being conducted?

This trial is being conducted at Bloomington, United States.

Who is sponsoring the NCT06991192 clinical trial?

NCT06991192 is sponsored by HealthPartners Institute. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology